TY - JOUR
T1 - First international TNBC conference meeting report
AU - Rida, Padmashree
AU - Ogden, Angela
AU - Ellis, Ian O.
AU - Varga, Zsuzsanna
AU - Wolff, Antonio C.
AU - Traina, Tiffany A.
AU - Hatzis, Christos
AU - Palmer, Julie R.
AU - Ambrosone, Christine B.
AU - Lehmann, Brian D.
AU - Nanda, Rita
AU - Montgomery Rice, Valerie
AU - Brawley, Otis W.
AU - Torres, Mylin A.
AU - Rakha, Emad
AU - Aneja, Ritu
N1 - Publisher Copyright:
© 2018, Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2018/6/1
Y1 - 2018/6/1
N2 - Recently, Georgia State University’s Centennial Hall was the premier location for the 2017 International Conference on Triple Negative Breast Cancer (TNBC): Illuminating Actionable Biology, which was held from Sept. 18 to 20, 2017, in Atlanta, USA. The conference featured a stellar line-up of domestic and international speakers and diverse participants including TNBC survivors, luminaries in breast cancer research, medical students and fellows, clinicians, translational researchers, epidemiologists, biostatisticians, bioinformaticians, and representatives from the industry. This report distills the burning questions that spiked the event and summarizes key themes, findings, unique opportunities and future directions that emerged from this confluence of thought leaders.
AB - Recently, Georgia State University’s Centennial Hall was the premier location for the 2017 International Conference on Triple Negative Breast Cancer (TNBC): Illuminating Actionable Biology, which was held from Sept. 18 to 20, 2017, in Atlanta, USA. The conference featured a stellar line-up of domestic and international speakers and diverse participants including TNBC survivors, luminaries in breast cancer research, medical students and fellows, clinicians, translational researchers, epidemiologists, biostatisticians, bioinformaticians, and representatives from the industry. This report distills the burning questions that spiked the event and summarizes key themes, findings, unique opportunities and future directions that emerged from this confluence of thought leaders.
KW - Immunotherapy
KW - Molecular subtypes
KW - Racial disparities
KW - Targeted drugs
KW - Triple negative breast cancer
UR - http://www.scopus.com/inward/record.url?scp=85041501196&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85041501196&partnerID=8YFLogxK
U2 - 10.1007/s10549-018-4692-3
DO - 10.1007/s10549-018-4692-3
M3 - Review article
C2 - 29417299
AN - SCOPUS:85041501196
SN - 0167-6806
VL - 169
SP - 407
EP - 412
JO - Breast Cancer Research and Treatment
JF - Breast Cancer Research and Treatment
IS - 3
ER -